University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

A 49-year-old scientist successfully treated her breast cancer by using a virus she grew in the lab. Her self-treatment ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

At 39, Beth Rogers-Payne was not surprised when she learned she had triple negative breast cancer in July of last year.

2024 年第 47 届 圣安东尼奥乳腺癌研讨会（San Antonio Breast Cancer Symposium，SABCS）将于 2024 年 12 月 10-13 日在美国圣安东尼奥隆重召开。SABCS ...